Journal
ONCOIMMUNOLOGY
Volume 1, Issue 8, Pages 1392-1394Publisher
LANDES BIOSCIENCE
DOI: 10.4161/onci.20926
Keywords
dendritic cells; immune monitoring; DC-therapy; skin infiltrating lymphocytes; HLA restriction
Categories
Ask authors/readers for more resources
A decade of collective work by tumor immunologists has led to improved large scale generation, maturation, antigen loading and administration of dendritic cells (DCs) to cancer patients, promoting enhanced antitumor activity. We alleviated the HLA-restriction in DC therapy and demonstrated that it is meaningful to treat patients with DCs irrespective of their HLA type.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
